Par Hallberg

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. ncbi request reprint The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial
    Par Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    J Hypertens 20:2089-93. 2002
  2. ncbi request reprint Digoxin and mortality in atrial fibrillation: a prospective cohort study
    Par Hallberg
    Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Uppsala University, 751 85, Uppsala, Sweden
    Eur J Clin Pharmacol 63:959-71. 2007
  3. ncbi request reprint The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects
    Par Hallberg
    Department of Clinical Pharmacology, Uppsala University Hospital, Uppsala, Sweden
    J Clin Psychopharmacol 25:59-73. 2005
  4. ncbi request reprint Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
    P Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cardiol 27:287-90. 2004
  5. ncbi request reprint Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
    Par Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cardiol 27:169-73. 2004
  6. pmc Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy
    Par Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    BMC Cardiovasc Disord 3:11. 2003
  7. ncbi request reprint B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial
    Par Hallberg
    Department of Medical Sciences, Clinical Research Department 2, Uppsala University Hospital, 75185 Uppsala, Sweden
    J Hypertens 21:621-4. 2003
  8. doi request reprint The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (
    Lisa Kurland
    Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    Am J Hypertens 21:836-9. 2008
  9. doi request reprint A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system
    Sofie Schwan
    Uppsala Drug Information Center, Uppsala County Council, Uppsala, Sweden
    Eur J Clin Pharmacol 66:947-53. 2010
  10. ncbi request reprint Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment
    Par Hallberg
    Department of Medical Sciences, Clinical Chemistry and Pharmacology, University Hospital, Uppsala, Sweden
    Ups J Med Sci 109:247-53. 2004

Detail Information

Publications13

  1. ncbi request reprint The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial
    Par Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    J Hypertens 20:2089-93. 2002
    ..However, its influence on clinical response to treatment with the AT(1) receptor antagonist, irbesartan, has not been investigated...
  2. ncbi request reprint Digoxin and mortality in atrial fibrillation: a prospective cohort study
    Par Hallberg
    Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, Uppsala University, 751 85, Uppsala, Sweden
    Eur J Clin Pharmacol 63:959-71. 2007
    ..No study has investigated a priori the effect of digoxin on mortality in patients with AF. This study aimed to address this question...
  3. ncbi request reprint The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects
    Par Hallberg
    Department of Clinical Pharmacology, Uppsala University Hospital, Uppsala, Sweden
    J Clin Psychopharmacol 25:59-73. 2005
    ..We here review and discuss those studies which have been published so far on this subject...
  4. ncbi request reprint Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
    P Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cardiol 27:287-90. 2004
    ..No study has yet determined the effect of this polymorphism on the change in blood pressure during antihypertensive treatment...
  5. ncbi request reprint Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
    Par Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    Clin Cardiol 27:169-73. 2004
    ..The TGF-beta1 G + 915C polymorphism is associated with interindividual variation in TGF-beta1 production. No study has yet determined the impact of this polymorphism on the response to antihypertensive treatment...
  6. pmc Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy
    Par Hallberg
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    BMC Cardiovasc Disord 3:11. 2003
    ..The enzyme seems to be particularly abundant in the heart. Recently, the Arg528-encoding allele of the ALAP gene was shown to be associated with essential hypertension...
  7. ncbi request reprint B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial
    Par Hallberg
    Department of Medical Sciences, Clinical Research Department 2, Uppsala University Hospital, 75185 Uppsala, Sweden
    J Hypertens 21:621-4. 2003
    ..We aimed to clarify whether the processes found in exercise-induced LV growth in normotensive people also occur in pathological LV hypertrophy...
  8. doi request reprint The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (
    Lisa Kurland
    Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden
    Am J Hypertens 21:836-9. 2008
    ..The aim of this study was to investigate the effect of the plasma concentration of irbesartan, a specific angiotensin II type 1 receptor (AT1R) antagonist, and the blood pressure response in relation to AT1R gene polymorphisms...
  9. doi request reprint A signal for an abuse liability for pregabalin--results from the Swedish spontaneous adverse drug reaction reporting system
    Sofie Schwan
    Uppsala Drug Information Center, Uppsala County Council, Uppsala, Sweden
    Eur J Clin Pharmacol 66:947-53. 2010
    ..As a GABA analogue, there has been some concern about an abuse liability. We aimed to investigate the possible abuse liability of pregabalin...
  10. ncbi request reprint Cystatin C vs creatinine as markers of renal function in patients on digoxin treatment
    Par Hallberg
    Department of Medical Sciences, Clinical Chemistry and Pharmacology, University Hospital, Uppsala, Sweden
    Ups J Med Sci 109:247-53. 2004
    ..Serum cystatin C has been suggested to be superior to creatinine for estimation of GFR, which may have relevance for the optimization of treatment with digoxin...
  11. pmc Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring
    Gunilla Englund
    Department of Medical Sciences, Uppsala University, Uppsala, Sweden
    BMC Med 2:8. 2004
    ..The question of whether several P-gp inhibitors may have additive effects has not yet been addressed...
  12. doi request reprint Data mining in pharmacovigilance--detecting the unexpected: the role of index of suspicion of the reporter
    Anders Sundström
    Department of Drug Safety, Medical Products Agency, Uppsala, Sweden
    Drug Saf 32:419-27. 2009
    ..As this type of ADR is often mistaken for a spontaneous disease, the causative agent may appear as an innocent bystander...